Page last updated: 2024-10-26

etilefrine and Pancreatic Neoplasms

etilefrine has been researched along with Pancreatic Neoplasms in 2 studies

Etilefrine: A phenylephrine-related beta-1 adrenergic and alpha adrenergic agonist used as a cardiotonic and antihypotensive agent.

Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koga, C1
Murakami, M1
Shimizu, J1
Yasuyama, A1
Matsumura, T1
Takata, A1
Kameda, C1
Kawabata, R1
Hirota, M1
Noura, S1
Hasegawa, J1
Jans, B1
Dusart, D1

Other Studies

2 other studies available for etilefrine and Pancreatic Neoplasms

ArticleYear
[A Case of Successful Management of Postoperative Chylous Ascites by Combination Therapy with Octreotide and Etilefrine].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:3

    Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chylous Ascites; Drainage; Etilef

2018
[Thrombosis of both carotid arteries, arterial hypotension and cancer of the pancreas].
    Bruxelles medical, 1979, Volume: 59, Issue:10

    Topics: Aged; Carotid Artery Thrombosis; Ethanolamines; Etilefrine; Humans; Hypotension; Male; Mephentermine

1979